Global disease burden of breast cancer attributable to high fasting plasma glucose: a comprehensive analysis from the global burden of disease study
Substantial disparities exist across diverse regions in breast cancer burden attributed to HFPG. It is urgent to regulate glycemic levels, improve healthcare infrastructures, and provide cost-effective care in less developed and developing countries that endure a disproportionately heavier health burden.
Authors
- Yunyan Lu (ORCID: https://orcid.org/0009-0006-7436-7763)
- Jiawei He (ORCID: https://orcid.org/0000-0002-6666-5916)
- Tian Lan (ORCID: https://orcid.org/0000-0002-6946-5776)
- Jing Zhang (ORCID: https://orcid.org/0000-0002-3577-4677)
Institutions
- Zhejiang Chinese Medical University (CN)
- Wenzhou Medical University (CN)
- Hangzhou Hospital of Traditional Chinese Medicine (CN)
- The First People's Hospital of Xiaoshan District, Hangzhou (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-02-13
- DOI
- https://doi.org/10.3389/fendo.2025.1498207
- Citations
- 1
- Primary Topic
- Cancer Risks and Factors
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Zhejiang Traditional Chinese Medicine Administration